Jane Street
CURX

Jane Street’s Curanex Pharmaceuticals CURX Stock Holding History

Jane Street’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.28K Buy
+1,561
New +$11.4K ﹤0.01% 11321
2026
Q1 		– Sell
-1,250
Closed -$8.26K – 13567
2025
Q4 		$8.26K Sell
1,250
-514
-29% -$5.66K ﹤0.01% 10866
2025
Q3 		$25.4K Buy
+1,764
New +$160K ﹤0.01% 10491

Other funds holding CURX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jane Street's CURX Position: Q2 2026 in Review

Jane Street opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 1,561 shares worth $8.28K. The stake represents ﹤0.01% of the portfolio and ranks #11321 among its holdings. This is a return to the name: Jane Street previously reported a position in CURX as recently as Q4 2025.

Jane Street first reported a position in CURX in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.4K in Q3 2025. 11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Jane Street held 1,561 shares of Curanex Pharmaceuticals worth $8.28K as of Q2 2026.
  • Curanex Pharmaceuticals was a new Jane Street position in Q2 2026.
  • Curanex Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11321 holding.
  • Jane Street first reported a position in Curanex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Jane Street's Curanex Pharmaceuticals position peaked at $25.4K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.